Adjuvant chemotherapy in stage I uterine endometrial carcinoma

International Journal of Gynecology and Obstetrics

Volumn 78, Issue 1, 2002, Pages 37-44

  Hirai, M ^a   Hirono, M ^a   Oosaki, T ^a   Hayashi, Y ^a   Yoshihara, T ^a   Itami, M ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

Adjuvant chemotherapy; Endometrial carcinoma; Lymph vascular space invasion

Indexed keywords

CYCLOSIDE; CYTARABINE; DOXIFLURIDINE; FLUOROURACIL; MITOMYCIN C; MITOMYCIN S; UFT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIUM CARCINOMA; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INFECTION; LUNG TOXICITY; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TOXICITY; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 0036310856     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(02)00069-3     Document Type: Article

References (25)

1. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study
2. Endometrial adenocarcinoma in Norway. A study of a total population
3. Lymphvascular space involvement - A prognostic indicator in endometrial adenocarcinoma
4. Prognostic factors in endometrial cancer
5. Prognostic factors relating to survival in uterine endometrial carcinoma
6. Relationship between surgical pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study
7. Predictors of recurrence in surgical stage II endometrial adenocarcinoma
8. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma
9. Stage I endometrial carcinoma: A review of 140 patients primarily treated by surgery only
10. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma
11. Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma
12. External pelvic radiation therapy in stage IC endometrial carcinoma
13. Benefit of adjuvant radiotherapy in surgically staged stage I-II endometrial carcinoma
14. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group study 1
15. The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma
16. Studies on the screening test of anti cancer drugs
17. The grading of lymphovascular space invasion in endometrial carcinoma
18. Multicenter randomized prospective study of adjuvant chemotherapy with UFT and mitomycin C in advanced colorectal cancer
19. Prospective study on the dose relationship of mitomycin C-induced interstitial pneumonitis
20. Antitumor antibiotics and related compounds
21. Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoids
22. Analysis of complications in patients with endometrial carcinoma receiving adjuvant irradiation
23. Phase I and pharmacokinetic study of oral paclitaxel